companydata.dkcompanydata.dk

Evaxion A/S: Financial statements 2022

CVR: 31762863

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Evaxion A/S (CVR 31762863) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -164,292,000 compared with DKK -154,885,000 the year before. Equity in the 2022 report amounted to DKK 57,888,000. The solvency ratio was 38.5%. The company had 59 employees in the financial year.

Profit/Loss
DKK -164,292,000
Equity
DKK 57,888,000
Total Assets
DKK 150,437,000
Employees
59

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022---164.3 mio.57.9 mio.59
2021---154.9 mio.212.8 mio.53
2020---97.9 mio.42.6 mio.33
2019---10.8 mio. USD9.3 mio. USD-
2018--8.4 mio.-17.1 mio.38.4 mio.18

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Evaxion A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Per Göran Oskar Norlén joins Evaxion A/S as adm. dir.Oct 1, 2022

As of October 1, 2022, Per Göran Oskar Norlén is registered as adm. dir. of Evaxion A/S.

Lars Aage Staal Wegner steps down as adm. dir. of Evaxion A/SOct 1, 2022

As of October 1, 2022, Lars Aage Staal Wegner has stepped down as adm. dir. of Evaxion A/S.

Evaxion A/S: The 2021 annual report is outMay 23, 2022

Evaxion A/S has published its annual report for 2021. The net result was DKK -154,885,000.

Bo Løkke Karmark joins Evaxion A/S as directorMay 23, 2022

As of May 23, 2022, Bo Løkke Karmark is registered as director of Evaxion A/S.

Niels Iversen Møller joins the board of Evaxion A/SMay 3, 2022

As of May 3, 2022, Niels Iversen Møller has joined the board of directors of Evaxion A/S.

Niels Iversen Møller steps down as director of Evaxion A/SApr 1, 2022

As of April 1, 2022, Niels Iversen Møller has stepped down as director of Evaxion A/S.

About Evaxion A/S

Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Helen Katrina Tayton-Martin, Andreas Holm Mattsson and Thomas Frederik Schmidt. The board consists of Marianne Søgaard (chair), Jens Bitsch-Nørhave, Lars Holtug and Lars Aage Staal Wegner. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 44 employees (2026). In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity in the 2025 report amounted to DKK 108,250,000.

Source: annual report 2025, Danish Business Authority